CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...
At the April Sampson Cancer Center on Monday, Tom Uhlman shared his story as part of the Shine a Light on Lung Cancer ...
Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.
RNA from the COVID-19 infection in patients with certain metastatic cancers may be associated with tumor shrinkage, but more ...
Mumbai, Maharashtra, India Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 ...
When you blocked someone on Twitter, you could no longer see them and they could no longer see you. Now when you block ...
The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.
Calidi Biotherapeutics, Inc. recently disclosed information revealing the latest advancements in its targeted antitumor virotherapies. The company’s press release, titled “Calidi Biotherapeutics ...
Medpage Today on MSN2d
Treatment of Oligometastatic EGFR-Mutant Lung CancerEGFR tyrosine kinase inhibitors (TKIs) are effective treatments for EGFR-mutant non-small cell lung cancer (NSCLC). However, ...
GlobalData on MSN2d
Novocure secures FDA approval for add-ons to brain cancer treatment wearableNovocure has refined the transducer arrays that attach to Optune Gio, its wearable for glioblastoma treatment.
"Metastatic breast cancer is where breast cancer moves from the origin in the breast through the blood, and through the lymph ...
Phase 1/2 dose escalation study to evaluate BriaCell’s personalized next generation immunotherapy treatment in metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback